CDK5 serves as a major control point in neurotransmitter release.
CDK5 is an important kinase in nervous system function, controlling neural development and postsynaptic signal integration. Here we show that CDK5 plays a major role in controlling neurotransmitter release. Inhibition of CDK5 activity, by either acute or genetic means, leads to profound potentiation of presynaptic function, including unmasking of previously "silent" synapses. Removal of CDK5 activity additionally unlocks access to the resting synaptic vesicle pool, which normally remains recalcitrant to exocytosis and recycling even following prolonged action potential stimuli. Presynaptic CDK5 levels are additionally severely depleted by chronic neuronal silencing, a treatment that is functionally similar to CDK5 knockdown with regard to presynaptic potentiation. Thus CDK5 appears to be an integral element in presynaptic homeostatic scaling, and the resting vesicle pool appears to provide a potent functional presynaptic homeostatic control parameter. These studies thus pinpoint CDK5 as a major control point for modulation of neurotransmitter release in mammalian neurons.
Kim
Sung Hyun
SH
Department of Biochemistry, Weill Cornell Medical College, New York, NY 10065, USA.
Ryan
Timothy A
TA
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D051360:Cyclin-Dependent Kinase 5 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D004558:Electric Stimulation / Q000379:methods; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D049452:Green Fluorescent Proteins / Q000235:genetics; D006624:Hippocampus / Q000166:cytology; D066298:In Vitro Techniques; D051938:Munc18 Proteins / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D018377:Neurotransmitter Agents / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077546:Roscovitine; D026941:Sodium Channel Blockers / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects / Q000502:physiology*; D013779:Tetrodotoxin / Q000494:pharmacology; D014162:Transfection / Q000379:methods; D014633:Valine / Q000031:analogs & derivatives / Q000494:pharmacology; D050988:Vesicle-Associated Membrane Protein 2 / Q000378:metabolism
D018691:Excitatory Amino Acid Antagonists; D051938:Munc18 Proteins; D018377:Neurotransmitter Agents; D047428:Protein Kinase Inhibitors; D011687:Purines; D034741:RNA, Small Interfering; D026941:Sodium Channel Blockers; D050988:Vesicle-Associated Membrane Protein 2; D000077546:Roscovitine; D049452:Green Fluorescent Proteins; D013779:Tetrodotoxin; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; C056639:2-amino-5-phosphopentanoic acid; D051360:Cyclin-Dependent Kinase 5; C495907:Cdk5 protein, rat; D014633:Valine
J Neurosci. 2002 Apr 1;22(7):2590-7
11923424
Trends Mol Med. 2004 Sep;10(9):452-8
15350898
J Cell Biol. 2003 Nov 24;163(4):813-24
14623869
Nat Neurosci. 2009 Jun;12(6):751-8
19430474
Neuron. 2006 Jul 6;51(1):71-84
16815333
J Biol Chem. 2002 Aug 30;277(35):31988-93
12084709
Brain Cell Biol. 2008 Aug;36(1-4):87-100
18941900
Cell. 2010 May 28;141(5):846-58
20510931
Neuron. 2005 Feb 17;45(4):563-73
15721242
Nat Neurosci. 2006 Jun;9(6):752-60
16648848
Annu Rev Neurosci. 2006;29:307-23
16776588
Biophys J. 2000 Oct;79(4):2199-208
11023924
J Biol Chem. 2006 Apr 14;281(15):9852-8
16461345
Neuron. 2002 Dec 19;36(6):1103-14
12495625
J Biol Chem. 2007 Mar 16;282(11):7869-76
17224448
Neuroreport. 2000 Jul 14;11(10):2213-6
10923673
Neuron. 1995 May;14(5):983-9
7748565
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2191-6
14769920
J Neurosci. 2002 Sep 15;22(18):7879-91
12223541
Cell. 2008 Oct 31;135(3):422-35
18984155
Neuron. 2007 Dec 6;56(5):823-37
18054859
Neuron. 2005 Sep 1;47(5):725-37
16129401
J Biol Chem. 2009 Nov 20;284(47):32803-12
19762466
J Biol Chem. 1998 Feb 27;273(9):4957-66
9478941
J Biol Chem. 1996 Aug 30;271(35):21108-13
8702879
Results Probl Cell Differ. 2000;30:241-53
10857192
Cell. 2001 Nov 30;107(5):617-29
11733061
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12748-53
11675506
Trends Neurosci. 2001 Nov;24(11):659-65
11672811
Neuron. 2009 Feb 26;61(4):556-69
19249276
J Biol Chem. 1999 Feb 12;274(7):4027-35
9933594
J Neurosci. 2009 Mar 25;29(12):3865-74
19321783
Neurosci Res. 2005 Apr;51(4):435-43
15740806
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20576-81
18077369
Nat Neurosci. 2007 Jul;10(7):880-886
17529984
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3679-83
8622996
J Neurosci. 1999 Feb 15;19(4):1317-23
9952409
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6131-6
15837917
Nat Neurosci. 2007 Feb;10(2):145-7
17220885
Mini Rev Med Chem. 2007 Oct;7(10):1070-4
17979810
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18567-71
19017796
J Biol Chem. 2008 Jun 27;283(26):18227-37
18460467
Nat Neurosci. 2001 Feb;4(2):129-36
11175872
Neuron. 2001 Nov 20;32(4):673-82
11719207
J Physiol. 2002 May 1;540(Pt 3):761-70
11986366
J Neurosci. 2008 Apr 2;28(14):3631-43
18385322
Nat Cell Biol. 2003 Aug;5(8):701-10
12855954
Nat Neurosci. 2007 Aug;10(8):1012-9
17632506
Trends Cell Biol. 2006 Aug;16(8):413-20
16839766